Label Changes for:
Inlyta (axitinib) tablets
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
6 ADVERSE REACTIONS
- addition of adverse drug reactions (Table 1)
- addition of hypercalcemia (Table 2)